EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators

Vinitha Richard, Madhumathy G Nair iD, Vishnu S Jaikumar, Sara Jones, Jyothi S Prabhu iD, Michael J Kerin

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Vinitha Richard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Surgery, Lambe Institute for Translational Research, University of Galway, H91 V4AY Galway, Ireland. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Precision Oncology Ireland (POI)-NBCRI, National Breast Cancer Research Institute (NBCRI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Luminal breast cancer subtypes respond poorly to endocrine and trastuzumab treatments due to cellular heterogeneity arising from the phenotype transitions, accounted for mainly by the loss of receptor expression. The origins of basal-like and human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer subtypes have been attributed to genetic and protein modifications in stem-like cells and luminal progenitor cell populations, respectively. The post-transcriptional regulation of protein expression is known to be influenced by microRNAs (miRNAs) that are deemed to be master regulators of several biological processes in breast tumorigenesis and progression. Our objective was to identify the fractions of luminal breast cancer cells that share stemness potentials and marker profiles and to elucidate the molecular regulatory mechanism that drives transitions between fractions, leading to receptor discordances. Established breast cancer cell lines of all prominent subtypes were screened for the expression of putative cancer stem cell (CSC) markers and drug transporter proteins using a side population (SP) assay. Flow-cytometry-sorted fractions of luminal cancer cells implanted in immunocompromised mice generated a pre-clinical estrogen receptor alpha (ERα+) animal model with multiple tumorigenic fractions displaying differential expression of drug transporters and hormone receptors. Despite an abundance of estrogen receptor 1 (ESR1) gene transcripts, few fractions transitioned to the triple-negative breast cancer (TNBC) phenotype with a visible loss of ER protein expression and a distinct microRNA expression profile that is reportedly enriched in breast CSCs. The translation of this study has the potential to provide novel therapeutic miRNA-based targets to counter the dreaded subtype transitions and the failure of antihormonal therapies in the luminal breast cancer subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsHumansAnimalsMiceFemaleErb-b2 Receptor Tyrosine KinasesTrastuzumabBreastPhenotypeReceptors, Progesterone

Stichwörter der Autor:innen

cancer stem cellsdrug transporter proteinshormone receptorsintratumoral heterogeneityluminal breast cancermicroRNAphenotypic transitionside population cellstumor subtypestumorigenic potential

Substanzen

MicroRNAsErb-b2 Receptor Tyrosine KinasesTrastuzumabReceptors, Progesterone

Autor:innen und Institutionen

  • Discipline of Surgery, Lambe Institute for Translational Research, University of Galway, H91 V4AY Galway, Ireland.
  • Division of Molecular Medicine, St. John's Research Institute, Bangalore 560034, Karnataka, India.
  • Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695585, Kerala, India.

ORCID-Profile: Madhumathy G Nair, Jyothi S Prabhu

Förderung

  • Precision Oncology Ireland (POI)-NBCRI
  • National Breast Cancer Research Institute (NBCRI)

Zitieren

APA

Richard, V., Nair, M. G., Jaikumar, V. S., Jones, S., Prabhu, J. S., & Kerin, M. J. (2023). Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043497

Vancouver

Richard V, Nair MG, Jaikumar VS, Jones S, Prabhu JS, Kerin MJ. Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043497

BibTeX
@article{Richard2023,
  author = {Richard, Vinitha and Nair, Madhumathy G and Jaikumar, Vishnu S and Jones, Sara and Prabhu, Jyothi S and Kerin, Michael J},
  title = {Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043497}
}
Kostenlos starten →